India to Chile: Ambroxol Export Trade Route
India has recorded 65 verified shipments of Ambroxol exported to Chile, representing a combined trade value of $773.6K USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $11.9K USD. The leading Indian exporter is SANPRAS HEALTHCARE PRIVATE LIMITED , which accounts for 47% of total export value with 27 shipments worth $362.3K USD. On the buying side, OPKO CHILE S.A., is the largest importer in Chile with $362.3K USD in purchases. The top 3 suppliers — SANPRAS HEALTHCARE PRIVATE LIMITED , SANPRAS HEALTHCARE PRIVATE LIMITED, BAROQUE PHARMACEUTICALS PVT LTD — together control 84% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Chile Ambroxol corridor is one of India's established pharmaceutical export routes, with 65 shipments documented worth a combined $773.6K USD. The route is dominated by SANPRAS HEALTHCARE PRIVATE LIMITED , which alone accounts for roughly 47% of all export value, reflecting the consolidated nature of India's ambroxol manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $11.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 31.8%, placing it at rank #3 among India's top ambroxol export destinations globally.
On the import side, key buyers of Indian ambroxol in Chile include OPKO CHILE S.A., , OPKO CHILE S.A.,, SEVEN PHARMA CHILE SPA., and 9 others. OPKO CHILE S.A., is the single largest importer with 27 shipments valued at $362.3K USD.
